R&D Views & Analysis | pharmaphorum

Views & Analysis

Digital

How patient-on-a-chip tech could be the future of drug disco...

Testing drug compounds on a chip designed to mimic human organs sounds closer to science fiction than reality, yet the technology already exists and is already being put to use.

R&D

Big pharma vs small diseases: Tackling rare diseases

Rare diseases aren’t as rare as the appellation suggests.

R&D

Achieving diversity, equity and inclusion in clinical trials

Making sure clinical trials are diverse and representative of the populations they’re studying isn’t just the right thing to do to promote inclusivity and equity; it’s also just good scienc

R&D

3D rendering of human intestine villi and microbiome

Understanding the microbiome as an ‘overlooked critical orga...

Compared to a ‘critical organ’ that had been largely ignored, companies working to develop microbiome-based therapies believe there is untapped potential in the area.

R&D

CRISPR therapies targeting the next breakthrough in oncology

The potential of CRISPR technology has been a hot topic in the industry ever since it was first developed, but as trials progress further into the clinic, what therapeutic areas could be se

R&D